PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-Mar-2024 AI in Genomics Market to Witness Phenomenal Surge, Projected to Reach USD 35,267.3 Million by 2033 Wired Release
21-Mar-2024 Healthcare BPO Market Estimated To Reach USD 908 Billion By 2032, With Round About 9.9% CAGR Wired Release
21-Mar-2024 Research Predicts Exponential Rise in Global AI in Medical Diagnostics Market, Reaching USD 10.6 Billion by 2033 Wired Release
21-Mar-2024 New Study Highlights Growth Opportunities in Medical Panel PC Market Through 2033 | Market.us Wired Release
21-Mar-2024 Gene Therapy Market Valuation Expected To Hit USD 49.3 Billion By 2032, Demonstrating A 25% CAGR Wired Release
21-Mar-2024 Legal Marijuana Market Will Increase USD 86.3 Billion By 2033 And Has Guessed Around 16.1% CAGR Wired Release
21-Mar-2024 Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply Eckert & Ziegler SE
21-Mar-2024 Pharmacy Market Expansion: Anticipated To Reach USD 1,750 Billion By 2032, Reflecting A 4.8% Growth Rate Wired Release
21-Mar-2024 Photodynamic Therapy Market Projected To Reach USD 5.0 Billion By 2033, With CAGR Of 8.3% Wired Release
21-Mar-2024 Cannabidiol Market Forecasted To Attain USD 97 Billion By 2032, Showcasing A 27% CAGR Wired Release
21-Mar-2024 Assisted Reproductive Technology Market Will Grow Nearly USD 179.4 Billion At A Rate Of 19.4% By 2032 Wired Release
21-Mar-2024 Genflow Biosciences PLC Announces Notification of Major Holdings AccessWire
21-Mar-2024 Genflow Biosciences PLC Announces Publication of a Key European Patent AccessWire
21-Mar-2024 High Potency Active Pharmaceutical Ingredients (HPAPI) Market Expected to Witness High Growth of 9% from 2024 to 2029 Medi-Tech Insights
21-Mar-2024 AEVIS VICTORIA SA (AEVS.SW) – Publication of the 2023 revenue AEVIS VICTORIA SA
21-Mar-2024 DocMorris AG: Significant earnings improvement in 2023; e-prescription is standard in Germany DocMorris AG
20-Mar-2024 Avinger Reports Fourth Quarter and Full Year 2023 Results AccessWire
20-Mar-2024 Heidelberg Pharma announces progress into Cohort 6 with its proprietary ATAC candidate HDP-101 in Phase I/IIa multiple myeloma study Heidelberg Pharma
20-Mar-2024 Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines Bayer AG and Thermo Fisher Scientific Inc
20-Mar-2024 Pharma sector backs Labour on R&D, research reveals Ayming UK